咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Research on the Identification... 收藏

Research on the Identification of Core Technologies of China’s Pharmaceutical Cold Chain Based on Patent Analysis

作     者:Yuan Hongmei Zhang Wenfeng Ma Junhong Zeng Yingying Meng Lingquan 

作者机构:School of Business AdministrationShenyang Pharmaceutical UniversityShenyang 110016China 

出 版 物:《Asian Journal of Social Pharmacy》 (亚洲社会药学(英文))

年 卷 期:2021年第16卷第2期

页      面:128-138页

学科分类:0202[经济学-应用经济学] 02[经济学] 020205[经济学-产业经济学] 

基  金:Source of the project:project supported by Liaoning Provincial Social Science Foundation-Research on Patent Legal Issues of Liaoning Traditional Chinese Medicine Manufacturing Industry Going Global Based on Technological Innovation(L18BFX011) 

主  题:pharmaceutical cold chain patent analysis IPC number co-occurrence K-cores analysis condorcet voting method 

摘      要:Objective To study the identification method that aims at the research and development target and makes the limited resources be *** the frequent occurrence of potential drug safety hazards and the vigorous development of biomedicine,China’s pharmaceutical cold chain is facing huge opportunities and *** this background,it’s vital to promote the research and development of Chinese pharmaceutical cold chain *** First,China’s pharmaceutical cold chain patents were sorted out through the literature research method and patent analysis method,de-noises and cleans the data,uses the international patent classification(IPC)numbers as the pharmaceutical cold chain ***,the IPC number co-occurrence matrix was ***,UCINET was used to visualize,draw the IPC number co-occurrence *** that,K-cores analysis was applied to initially screen the core technology so as to build a comprehensive evaluation index system to evaluate the core ***,Condorcet voting method was used to integrate the evaluation results to identify the core *** and Conclusion Based on this method,it can provide theoretical guidance for the development and decision-making of Chinese pharmaceutical cold chain enterprises,helping them break through technical barriers and improving the efficiency of Chinese pharmaceutical cold chain logistics.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分